Clinical Trial

Exploring the Nature, Assessment and Treatment of Stuttering

Recruiting
View on ClinicalTrials.gov →
Summary
The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-08.
Trial Details
NCT Number NCT05908123
Lead Sponsor University of Texas at Austin
Conditions Stuttering, Stuttering, Adult, Stuttering, Childhood, Stuttering, Developmental
Enrollment 3,000 participants
Start Date 2015-05-22
Primary Completion 2035-05-22 (estimated)
Study Completion 2035-05-22 (estimated)
Updated on ClinicalTrials.gov 2023-06-22